On CNBC’s “Halftime Report Final Trades,” Jenny Van Leeuwen Harrington, chief executive officer of Gilman Hill Asset Management, LLC, picked The Charles Schwab Corporation (NYSE:SCHW).

Compass Point analyst Ed Engel, on Aug. 3, initiated coverage on Charles Schwab with a Buy rating and announced a price target of $135.

Jim Lebenthal, partner and chief market strategist at Cerity Partners, recommended Cleveland-Cliffs Inc. (NYSE:CLF), which recorded gains on Wednesday.

JP Morgan analyst Bennett Moore, on Sept. 9, maintained a Neutral rating on Cleveland-Cliffs and raised the price target from $11 to $13.

Don’t forget to check out our premarket coverage here

Stephen Weiss, chief investment officer and managing partner of Short Hills Capital Partners, named UnitedHealth Group Incorporated (NYSE:UNH) as his final trade.

UnitedHealth Group said it will release its third-quarter financial results on Tuesday, Oct. 13, before the opening bell. Analysts expect the company to report quarterly earnings at $4.14 per share on revenue of $111.49 billion.

Joseph M. Terranova, senior managing director for Virtus Investment Partners, picked Incyte Corporation (NASDAQ:INCY).

Supporting his view, Canaccord Genuity analyst John Newman, on Aug. 20, initiated coverage on Incyte with a Buy rating and announced a price target of $152.

Price Action

• Charles Schwab shares fell 2.4% to close at $105.16 on Wednesday.
• Cleveland-Cliffs shares gained 3.1% to close at $12.15 during the session.
• UnitedHealth shares slipped 0.2% to settle at $375.26 on Wednesday.
• Incyte shares gained 2.5% to $124.75 during the session.

Photo via Shutterstock